{"nctId":"NCT02088073","briefTitle":"Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.","startDateStruct":{"date":"2014-03-31","type":"ACTUAL"},"conditions":["Hyperkalemia"],"count":258,"armGroups":[{"label":"Sodium zirconium cyclosilicate 10 g three times daily","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium zirconium cyclosilicate"]},{"label":"Placebo once daily","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Sodium zirconium cyclosilicate 5 g once daily","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium zirconium cyclosilicate"]},{"label":"Sodium zirconium cyclosilicate 10 g once daily","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium zirconium cyclosilicate"]},{"label":"Sodium zirconium cyclosilicate 15 g once daily","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium zirconium cyclosilicate"]}],"interventions":[{"name":"Sodium zirconium cyclosilicate","otherNames":["ZS; Microporous, Fractionated, Protonated Zirconium Silicate; Zirconium Silicate"]},{"name":"Placebo","otherNames":["Silicilate microcrystaline cellulose"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Provision of written informed consent.\n* Over 18 years of age.\n* Two consecutive i-STAT potassium values, measured 60-minutes apart, both ≥5.1 mmol/l and measured within 1 day of the first ZS dose on AP Study Day 1.\n* Ability to have repeated blood draws or effective venous catheterization.\n* Women of childbearing potential must be using two forms of medically acceptable contraception (at least one barrier method) and have a negative pregnancy test at AP Study Day 1. Women who are surgically sterile or those who are post-menopausal for at least 2 years are not considered to be of childbearing potential.\n\nExclusion Criteria:\n\n* Pseudohyperkalemia signs and symptoms, such as excessive fist clenching hemolyzed blood specimen, history of severe leukocytosis or thrombocytosis.\n* Subjects treated with lactulose, Xifaxan or other non-absorbed antibiotics for hyperammonemia within 7 days prior to the first dose of study drug.\n* Subjects treated with resins (such as sevelamer acetate or sodium polystyrene sulfonate \\[SPS; e.g. Kayexalate®\\]), calcium acetate, calcium carbonate, or lanthanum carbonate, within 7 days prior to the first dose of study drug.\n* Subjects with a life expectancy of less than 3 months.\n* Subjects who are severely physically or mentally incapacitated and who in the opinion of investigator are unable to perform the subjects' tasks associated with the protocol.\n* Women who are pregnant, lactating, or planning to become pregnant.\n* Subjects with diabetic ketoacidosis.\n* Presence of any condition which, in the opinion of the investigator, places the subject at undue risk or potentially jeopardizes the quality of the data to be generated.\n* Known hypersensitivity or previous anaphylaxis to ZS or to components thereof.\n* Randomization into the previous ZS-002 or ZS-003 studies.\n* Treatment with a drug or device within the last 30 days that has not received regulatory approval at the time of study entry.\n* Subjects with cardiac arrhythmias that require immediate treatment.\n* Subjects on dialysis.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Serum Potassium Between Maintenance Phase Study Days 8 to 29, Inclusive (MP-ITT Population).","description":"The least squares means (LSMeans) are dervied from a mixed effects model of serial log transformed S-K values between Days 8 and 29 with patients as a random effect and the following fixed effects terms: MP treatment group; AP baseline eGFR; AP and MP baseline S-K levels, age categories (\\<55, 55-64, \\>= 65 years); and binary indicators for RAAS inhibitors use, CKD, CHF, and DM. The LSmeans estimate obtained from the above model is back-transformed and presented as the lsmeans of all available S-K values during the Maintenance phase study Days 8 to 29.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0603","spread":null},{"groupId":"OG001","value":"4.7544","spread":null},{"groupId":"OG002","value":"4.5081","spread":null},{"groupId":"OG003","value":"4.3742","spread":null}]}]}]},{"type":"SECONDARY","title":"The Number of Normokalemic Days Between Maintenance Phase Study Days 8 to 29, Inclusive (MP-ITT).","description":"The number of normokalemic days during the Maintenance Phase Study Days 8 to 29 is calculated assuming that the interval between assessments is normokalemic only if both the beginning and end assessments for that time interval display normal S-K values (i.e. 3.5 - 5.0 mmol/L)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":"8.0"},{"groupId":"OG001","value":"13.4","spread":"7.57"},{"groupId":"OG002","value":"13.9","spread":"7.91"},{"groupId":"OG003","value":"16.8","spread":"6.99"}]}]}]},{"type":"SECONDARY","title":"Mean Change in S-K Levels From Acute Phase Baseline to Maintenance Phase Study Day 2 to Day 29/Exit .","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.55","spread":"0.471"},{"groupId":"OG001","value":"5.53","spread":"0.357"},{"groupId":"OG002","value":"5.58","spread":"0.423"},{"groupId":"OG003","value":"5.55","spread":"0.331"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.86","spread":"0.508"},{"groupId":"OG001","value":"-1.03","spread":"0.408"},{"groupId":"OG002","value":"-1.25","spread":"0.471"},{"groupId":"OG003","value":"-1.12","spread":"0.477"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.49","spread":"0.549"},{"groupId":"OG001","value":"-0.72","spread":"0.552"},{"groupId":"OG002","value":"-1.09","spread":"0.629"},{"groupId":"OG003","value":"-1.20","spread":"0.592"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.41","spread":"0.508"},{"groupId":"OG001","value":"-0.75","spread":"0.516"},{"groupId":"OG002","value":"-1.11","spread":"0.663"},{"groupId":"OG003","value":"-1.20","spread":"0.665"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.48","spread":"0.612"},{"groupId":"OG001","value":"-0.77","spread":"0.492"},{"groupId":"OG002","value":"-1.11","spread":"0.652"},{"groupId":"OG003","value":"-1.19","spread":"0.627"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.45","spread":"0.549"},{"groupId":"OG001","value":"-0.79","spread":"0.520"},{"groupId":"OG002","value":"-1.04","spread":"0.581"},{"groupId":"OG003","value":"-1.07","spread":"0.575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.45","spread":"0.578"},{"groupId":"OG001","value":"-0.71","spread":"0.543"},{"groupId":"OG002","value":"-0.93","spread":"0.653"},{"groupId":"OG003","value":"-1.05","spread":"0.586"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"0.552"},{"groupId":"OG001","value":"-0.65","spread":"0.448"},{"groupId":"OG002","value":"-0.87","spread":"0.697"},{"groupId":"OG003","value":"-1.03","spread":"0.597"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.499"},{"groupId":"OG001","value":"-0.69","spread":"0.500"},{"groupId":"OG002","value":"-1.08","spread":"0.704"},{"groupId":"OG003","value":"-1.12","spread":"0.571"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","spread":"0.515"},{"groupId":"OG001","value":"-0.77","spread":"0.559"},{"groupId":"OG002","value":"-1.10","spread":"0.813"},{"groupId":"OG003","value":"-1.19","spread":"0.659"}]}]}]},{"type":"SECONDARY","title":"Mean Percent Change in S-K Levels From Acute Phase Baseline to Maintenance Phase Study Day 2 to Day 29/Exit, Inclusive .","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.11","spread":"8.154"},{"groupId":"OG001","value":"-18.53","spread":"6.941"},{"groupId":"OG002","value":"-22.19","spread":"7.897"},{"groupId":"OG003","value":"-20.04","spread":"7.959"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.45","spread":"9.492"},{"groupId":"OG001","value":"-12.84","spread":"9.700"},{"groupId":"OG002","value":"-19.16","spread":"10.708"},{"groupId":"OG003","value":"-21.29","spread":"10.135"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.22","spread":"8.967"},{"groupId":"OG001","value":"-13.36","spread":"8.949"},{"groupId":"OG002","value":"-19.45","spread":"11.072"},{"groupId":"OG003","value":"-21.22","spread":"11.368"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.28","spread":"10.739"},{"groupId":"OG001","value":"-13.73","spread":"8.485"},{"groupId":"OG002","value":"-19.33","spread":"10.884"},{"groupId":"OG003","value":"-21.19","spread":"10.675"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.87","spread":"9.554"},{"groupId":"OG001","value":"-14.08","spread":"8.822"},{"groupId":"OG002","value":"-18.29","spread":"9.707"},{"groupId":"OG003","value":"-19.10","spread":"9.957"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.74","spread":"9.992"},{"groupId":"OG001","value":"-12.65","spread":"9.591"},{"groupId":"OG002","value":"-16.25","spread":"11.292"},{"groupId":"OG003","value":"-18.65","spread":"10.034"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.54","spread":"9.386"},{"groupId":"OG001","value":"-11.83","spread":"8.025"},{"groupId":"OG002","value":"-15.18","spread":"11.988"},{"groupId":"OG003","value":"-18.28","spread":"10.271"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.23","spread":"8.586"},{"groupId":"OG001","value":"-12.49","spread":"8.770"},{"groupId":"OG002","value":"-18.83","spread":"11.951"},{"groupId":"OG003","value":"-19.80","spread":"9.503"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.68","spread":"8.940"},{"groupId":"OG001","value":"-13.85","spread":"9.568"},{"groupId":"OG002","value":"-19.28","spread":"14.099"},{"groupId":"OG003","value":"-21.06","spread":"11.086"}]}]}]},{"type":"SECONDARY","title":"Mean Change in S-K Levels From Maintenance Phase Baseline to Maintenance Phase Day 2 to Day 29/Exit.","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.55","spread":"0.427"},{"groupId":"OG001","value":"4.51","spread":"0.357"},{"groupId":"OG002","value":"4.38","spread":"0.407"},{"groupId":"OG003","value":"4.45","spread":"0.372"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.13","spread":"0.411"},{"groupId":"OG001","value":"-0.01","spread":"0.372"},{"groupId":"OG002","value":"-0.04","spread":"0.384"},{"groupId":"OG003","value":"-0.02","spread":"0.400"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.50","spread":"0.538"},{"groupId":"OG001","value":"0.30","spread":"0.467"},{"groupId":"OG002","value":"0.12","spread":"0.523"},{"groupId":"OG003","value":"-0.10","spread":"0.535"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.60","spread":"0.580"},{"groupId":"OG001","value":"0.26","spread":"0.541"},{"groupId":"OG002","value":"0.10","spread":"0.594"},{"groupId":"OG003","value":"-0.11","spread":"0.572"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.54","spread":"0.694"},{"groupId":"OG001","value":"0.25","spread":"0.535"},{"groupId":"OG002","value":"0.11","spread":"0.552"},{"groupId":"OG003","value":"-0.10","spread":"0.546"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.55","spread":"0.672"},{"groupId":"OG001","value":"0.22","spread":"0.580"},{"groupId":"OG002","value":"0.17","spread":"0.483"},{"groupId":"OG003","value":"0.01","spread":"0.605"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.55","spread":"0.627"},{"groupId":"OG001","value":"0.30","spread":"0.563"},{"groupId":"OG002","value":"0.27","spread":"0.650"},{"groupId":"OG003","value":"0.03","spread":"0.579"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.55","spread":"0.623"},{"groupId":"OG001","value":"0.34","spread":"0.565"},{"groupId":"OG002","value":"0.33","spread":"0.673"},{"groupId":"OG003","value":"0.05","spread":"0.594"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.52","spread":"0.545"},{"groupId":"OG001","value":"0.28","spread":"0.664"},{"groupId":"OG002","value":"0.14","spread":"0.668"},{"groupId":"OG003","value":"-0.04","spread":"0.554"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.56","spread":"0.582"},{"groupId":"OG001","value":"0.25","spread":"0.645"},{"groupId":"OG002","value":"0.11","spread":"0.768"},{"groupId":"OG003","value":"-0.09","spread":"0.598"}]}]}]},{"type":"SECONDARY","title":"Mean Percent Change in S-K Levels From Maintenance Phase Baseline to Maintenance Phase Day 2 to Day 29/Exit.","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.39","spread":"9.044"},{"groupId":"OG001","value":"0.06","spread":"8.036"},{"groupId":"OG002","value":"-0.51","spread":"8.862"},{"groupId":"OG003","value":"-0.20","spread":"8.984"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.64","spread":"12.291"},{"groupId":"OG001","value":"6.93","spread":"10.486"},{"groupId":"OG002","value":"3.05","spread":"12.346"},{"groupId":"OG003","value":"-1.74","spread":"12.043"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.70","spread":"13.072"},{"groupId":"OG001","value":"6.38","spread":"12.287"},{"groupId":"OG002","value":"2.85","spread":"13.595"},{"groupId":"OG003","value":"-2.00","spread":"12.836"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.51","spread":"15.693"},{"groupId":"OG001","value":"5.95","spread":"12.169"},{"groupId":"OG002","value":"2.93","spread":"12.662"},{"groupId":"OG003","value":"-1.89","spread":"12.118"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.96","spread":"15.791"},{"groupId":"OG001","value":"5.33","spread":"12.934"},{"groupId":"OG002","value":"4.28","spread":"11.231"},{"groupId":"OG003","value":".095","spread":"13.697"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.84","spread":"14.342"},{"groupId":"OG001","value":"6.98","spread":"12.774"},{"groupId":"OG002","value":"6.79","spread":"15.174"},{"groupId":"OG003","value":"1.39","spread":"12.782"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.03","spread":"14.566"},{"groupId":"OG001","value":"7.98","spread":"12.932"},{"groupId":"OG002","value":"8.08","spread":"15.516"},{"groupId":"OG003","value":"1.88","spread":"16.641"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.09","spread":"13.116"},{"groupId":"OG001","value":"6.12","spread":"14.424"},{"groupId":"OG002","value":"3.02","spread":"17.785"},{"groupId":"OG003","value":"-1.43","spread":"13.664"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.97","spread":"13.116"},{"groupId":"OG001","value":"6.12","spread":"14.424"},{"groupId":"OG002","value":"3.02","spread":"17.785"},{"groupId":"OG003","value":"-1.43","spread":"13.664"}]}]}]},{"type":"SECONDARY","title":"Median Time to Hyperkalemia (S-K ≥ 5.1mmol/L)","description":null,"paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"14","spread":null},{"groupId":"OG002","value":"NA","spread":null},{"groupId":"OG003","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean S-K Intra-subject Standard Deviation Calculated Among Subjects With ≥ 2 Values on or After Maintenance Phase Study Day 8","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06392","spread":null},{"groupId":"OG001","value":"0.06367","spread":null},{"groupId":"OG002","value":"0.07708","spread":null},{"groupId":"OG003","value":"0.06849","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Subjects Who Remained Normokalemic During Maintenance Phase","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.866","spread":null},{"groupId":"OG001","value":"0.933","spread":null},{"groupId":"OG002","value":"0.920","spread":null},{"groupId":"OG003","value":"0.926","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","spread":null},{"groupId":"OG001","value":"0.933","spread":null},{"groupId":"OG002","value":"0.918","spread":null},{"groupId":"OG003","value":"0.944","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.481","spread":null},{"groupId":"OG001","value":"0.711","spread":null},{"groupId":"OG002","value":"0.820","spread":null},{"groupId":"OG003","value":"0.852","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.400","spread":null},{"groupId":"OG001","value":"0.750","spread":null},{"groupId":"OG002","value":"0.787","spread":null},{"groupId":"OG003","value":"0.849","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.438","spread":null},{"groupId":"OG001","value":"0.705","spread":null},{"groupId":"OG002","value":"0.851","spread":null},{"groupId":"OG003","value":"0.827","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.449","spread":null},{"groupId":"OG001","value":"0.744","spread":null},{"groupId":"OG002","value":"0.787","spread":null},{"groupId":"OG003","value":"0.882","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.442","spread":null},{"groupId":"OG001","value":"0.674","spread":null},{"groupId":"OG002","value":"0.667","spread":null},{"groupId":"OG003","value":"0.882","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.486","spread":null},{"groupId":"OG001","value":"0.738","spread":null},{"groupId":"OG002","value":"0.711","spread":null},{"groupId":"OG003","value":"0.843","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.507","spread":null},{"groupId":"OG001","value":"0.667","spread":null},{"groupId":"OG002","value":"0.816","spread":null},{"groupId":"OG003","value":"0.907","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.476","spread":null},{"groupId":"OG001","value":"0.711","spread":null},{"groupId":"OG002","value":"0.760","spread":null},{"groupId":"OG003","value":"0.852","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Time to Relapse in S-K Values","description":"Median time to relapse in S-K values (return to original Acute Phase S-K baseline value)","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"29","spread":null},{"groupId":"OG002","value":"NA","spread":null},{"groupId":"OG003","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Exponential Rate of Change in S-K Values During the Acute Phase at 24 Hours and 48 Hours of Study Drug Treatment.","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.00373","spread":"0.000231"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.00324","spread":"0.000130"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in S-K Values (Blood) at All Measured Time Intervals Post Dose Acute Phase.","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.55","spread":"0.449"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.23","spread":"0.435"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.41","spread":"0.440"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.405"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.68","spread":"0.448"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.75","spread":"0.444"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.05","spread":"0.510"}]}]}]},{"type":"SECONDARY","title":"Mean Percent Change From Baseline in S-K Values (Blood) at All Measured Time Intervals Post Dose Acute Phase.","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.91","spread":"7.741"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.13","spread":"7.706"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.00","spread":"7.123"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.03","spread":"7.808"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.41","spread":"7.720"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.56","spread":"8.506"}]}]}]},{"type":"SECONDARY","title":"Proportion of Subjects Who Achieve Normokalemia During the Acute Phase at 24 and 48 Hours After Start of Dosing","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.661","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.88","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Time to Normalization (3.50-5.0 mmol/L) in S-K Levels in the 48 Hours of Initial Treatment","description":null,"paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.17","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":258},"commonTop":["Edema","Fatigue","Oedema peripheral","Constipation","Upper respiratory infection"]}}}